SES - Delayed Quote • SGD
Biolidics Limited (8YY.SI)
As of 9:55 AM GMT+8. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SGD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Tang Yih Song | CEO & Executive Director | -- | -- | 1965 |
| Prof. Chwee Teck Lim | Founder and Advisor | -- | -- | -- |
| Mr. Tan Swee Jin | Co-Founder and Technical Advisor | -- | -- | -- |
| Mr. Yeung Sau Siu CA | Financial Controller | -- | -- | 1974 |
| Dr. Ali Asgar Bhagat | Technical Director | -- | -- | -- |
| Mr. Hua Zhu | Executive Director | -- | -- | 1977 |
| Ms. Hafiza Alwi Nor FCIS | Company Secretary | -- | -- | -- |
Biolidics Limited
18 Howard Road
No.11-09 Novelty BizCentre
Singapore, 369585
Singapore
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 15
Description
Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions. The company operates through Cancer, Infectious Diseases, and Laboratory Services segments. It provides Covid-19 PCR testing kits. The company offers ClearCell FX1 System, an automated device that separates and enriches cancer cells from blood; and antigen and antibody test kits, as well as laboratory services. It serves academic and research institutes, hospitals, and laboratories in Singapore, China, Hong Kong, Japan, the United States, and other European Union countries. The company was incorporated in 2009 and is based in Singapore.
Corporate Governance
Biolidics Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Apr 26, 2024 - Apr 30, 2024
Biolidics Limited Earnings Call